Orkin, S. H. & Zon, L. I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132, 631–644 (2008).
Article CAS PubMed PubMed Central Google Scholar
Looker, A. C., Dallman, P. R., Carroll, M. D., Gunter, E. W. & Johnson, C. L. Prevalence of iron deficiency in the United States. J. Am. Med. Assoc. 277, 973–976 (1997).
Heegaard, E. D. & Brown, K. E. Human parvovirus B19. Clin. Microbiol. Rev. 15, 485 (2002).
Article PubMed PubMed Central Google Scholar
Afdhal, N. et al. Thrombocytopenia associated with chronic liver disease. J. Hepatol. 48, 1000–1007 (2008).
Article CAS PubMed Google Scholar
Nimer, S. D. Myelodysplastic syndromes. Blood 111, 4841–4851 (2008).
Article CAS PubMed Google Scholar
Babitt, J. L. & Lin, H. Y. Mechanisms of anemia in CKD. J. Am. Soc. Nephrol. 23, 1631–1634 (2012).
Article CAS PubMed PubMed Central Google Scholar
Weiss, G., Ganz, T. & Goodnough, L. T. Anemia of inflammation. Blood 133, 40–50 (2019).
Article CAS PubMed PubMed Central Google Scholar
Shimamura, A. & Alter, B. P. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 24, 101–122 (2010).
Article CAS PubMed PubMed Central Google Scholar
Slichter, S. J. Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transf. Med. Rev. 18, 153–167 (2004).
Chemaly, R. F. et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients - a retrospective study at a major cancer center. Medicine 85, 278–287 (2006).
Kuderer, N. M., Dale, D. C., Crawford, J., Cosler, L. E. & Lyman, G. H. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106, 2258–2266 (2006).
Wolach, O. & Stone, R. Autoimmunity and inflammation in myelodysplastic syndromes. Acta Haematol. 136, 108–117 (2016).
Article CAS PubMed Google Scholar
Caligaris-Cappio, F. & Hamblin, T. J. B-cell chronic lymphocytic leukemia: a bird of a different feather. J. Clin. Oncol. 17, 399–408 (1999).
Article CAS PubMed Google Scholar
Finkel, H. E., Brauer, M. J., Taub, R. N. & Dameshek, W. Immunologic aberrations in Di Guglielmo syndrome. Blood 28, 634–649 (1966).
Article CAS PubMed Google Scholar
Lewis, C. M. & Pegrum, G. D. Immune-complexes in myeloproliferative disorders. Lancet 2, 1151–1153 (1977).
Article CAS PubMed Google Scholar
Hetzel, P. & Gee, T. S. New observation in clinical spectrums of erythroleukemia - report of 46 cases. Am. J. Med. 64, 765–772 (1978).
Article CAS PubMed Google Scholar
Enright, H. et al. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes - response to immunosuppressive therapy. Brit. J. Haematol. 91, 403–408 (1995).
Colombat, P. H., Renoux, M., Lamagnere, J. P. & Renoux, G. immunological indexes in myelodysplastic syndromes. Cancer 61, 1075–1081 (1988).
Article CAS PubMed Google Scholar
Young, N. S., Calado, R. T. & Scheinberg, P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108, 2509–2519 (2006).
Article CAS PubMed PubMed Central Google Scholar
Green, A. R., Shuttleworth, D., Bowen, D. T. & Bentley, D. P. Cutaneous vasculitis in patients with myelodysplasia. Brit. J. Haematol. 74, 364–365 (1990).
Pagliuca, A., Higgins, E., Samson, D., Humphries, S. & Mufti, G. J. Prodromal cutaneous vasculitis in myelodysplastic syndromes. Brit. J. Haematol. 75, 444–446 (1990).
Hebbar, M. et al. Association of myelodysplastic syndrome and relapsing polychondritis - further evidence. Leukemia 9, 731–733 (1995).
Fernandezmiranda, C. et al. Vasculitis associated to myelodysplastic syndrome - report of 5 cases. Med. Clin. 103, 539–542 (1994).
Savige, J. A., Chang, L., Smith, C. L. & Duggan, J. C. Myelodysplasia, vasculitis and antineutrophil cytoplasm antibodies. Leuk. Lymphoma 9, 49–54 (1993).
Article CAS PubMed Google Scholar
Doutre, M. S. et al. Cutaneous vasculitis and refractory-anemia with excess of blast cells. Ann. Dermatol. Venereol. 114, 97–100 (1987).
Saif, M. W., Hopkins, J. L. & Gore, S. D. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk. Lymphoma 43, 2083–2092 (2002).
Giannouli, S., Voulgarelis, M., Zintzaras, E., Tzioufas, A. G. & Moutsopoulos, H. M. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology 43, 626–632 (2004).
Article CAS PubMed Google Scholar
de Hollanda, A. et al. Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study. Arthritis Care Res. 63, 1188–1194 (2011).
Mekinian, A. et al. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. Rheumatology 55, 291–300 (2016).
Article CAS PubMed Google Scholar
Anderson, L. A. et al. Risks of myeloid malignancies in patients with autoimmune conditions. Brit. J. Cancer 100, 822–828 (2009).
Article CAS PubMed PubMed Central Google Scholar
Kristinsson, S. Y. et al. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J. Clin. Oncol. 29, 2897–2903 (2011).
Article PubMed PubMed Central Google Scholar
Weeks, L. D. et al. Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood 139, 1246–1250 (2022). This analysis of SEER (Surveillance, Epidemiology, and End Results)–Medicare data shows greater prevalence of antecedent diseases of inflammageing in patients with MDS and chronic myelomonocytic leukaemia.
Article CAS PubMed PubMed Central Google Scholar
Sujobert, P. et al. Evidence of differentiation in myeloid malignancies associated neutrophilic dermatosis: a fluorescent in situ hybridization study of 14 patients. J. Invest. Dermatol. 133, 1111–1114 (2013).
Article CAS PubMed Google Scholar
Chavan, R. N. et al. Histiocytoid sweet syndrome may indicate leukemia cutis: a novel application of fluorescence in situ hybridization. J. Am. Acad. Dermatol. 70, 1021–1027 (2014).
Passet, M. et al. Next-generation sequencing in myeloid neoplasm-associated sweet’s syndrome demonstrates clonal relation between malignant cells and skin-infiltrating neutrophils. J. Invest. Dermatol. 140, 1873 (2020).
Article CAS PubMed Google Scholar
Magro, C. M., Kiani, B., Li, J. W. & Crowson, A. N. Clonality in the setting of Sweet’s syndrome and pyoderma gangrenosum is not limited to underlying myeloproliferative disease. J. Cutan. Pathol. 34, 526–534 (2007).
de Fremont, G. M. et al. Myeloid clonal infiltrate identified with next-generation sequencing in skin lesions associated with myelodysplastic syndromes and chronic myelomonocytic leukemia: a case series. Front. Immunol. 12, 715053 (2021).
Trowbridge, J. J. & Starczynowski, D. T. Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS. J. Exp. Med. 218, e20201544 (2021).
Article CAS PubMed PubMed Central Google Scholar
Caiado, F., Pietras, E. M. & Manz, M. G. Inflammation as a regulator of hematopoietic stem cell function in disease, and clonal selection. J. Exp. Med. 218, e20201541 (2021).
留言 (0)